ASCO: Pembrolizumab Improves Survival in Melanoma
Three-year overall survival rate of 40 percent; median overall survival of 24.4 months
FDA Approves Tecentriq to Treat Urothelial Carcinoma
FDA also approves a companion test to detect PD-L1 protein expression levels in patients
Cancer Treatment Lacking for HIV-Infected Patients
But it's not clear what's driving the difference in care, researcher says
Sexual Harassment Experienced by One-Third of Female Doctors
And two-thirds say they experience gender bias in workplace
Burnout, Lack of Job Satisfaction Driving Doctors to Cut Hours
Full-time physicians reporting worsening burnout or decreasing job satisfaction more likely to cut hours
ATS: Hydroxyurea Can Up Lung Function in Sickle Cell Disease
Drug slowed down the annual decline children had been showing before starting treatment
ATS: Aggressive Melanoma Linked to Severe, Untreated Sleep Apnea
Study highlights the importance of diagnosing and treating obstructive sleep apnea
Novel Index Predicts Survival After Chemo in Pancreatic Cancer
Systemic inflammation response index can predict time to progression and overall survival
Complementary Medicine Use Up With Chronic Conditions
Adults with two or more conditions more likely to use complementary and alternative medicine
Physical Activity Associated With Lower Risk of Many Cancers
Findings for self-reported leisure-time physical activity of moderate to vigorous intensity
